IN THIS ISSUE

Howard Wolinsky
Despite some initially impressive results and good intentions, some wonder if this mix of altruism and capitalism can succeed.
Jan Greene
They play a key role in the new payment models. But coordinators aren’t coordinated, and patients are getting annoyed—and worse.
Original Research
Brooke Roeper, MSPH, MS
Eric Beck, DO, MPH, FACEP
Daniel Castillo, MD, MBA
Medical Directors Forum
Mike Cantor, MD, JD

Mike Cantor, MD, JD
CareCentrix

Editor’s Memo
Peter Wehrwein
Legislation & Regulation
Richard Mark Kirkner

Sen. Susan Collins
(R-Maine)

Now it’s the Senate’s turn. The key players include Republican senators from states that expanded Medicaid and the upper chamber’s parliamentarian.
Medication Management
Thomas Reinke
The SGLT2 inhibitors and GLP-1 agonists may have a direct effect on heart failure and cardiovascular outcomes.
Viewpoint
Michael Schlosser, MD
Ronald Chamberlain, MD
Marcus Dortch, PharmD
News & Commentary
Frank Diamond
News & Commentary
News & Commentary
Frank Diamond